Cannabis Bioscience International Holdings (CBIH) Accounts Payables (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Accounts Payables across 4 years of filings, most recently posting $190467.0 for Q1 2026.

• Accounts Payables for Q1 2026 came in at $190467.0, up 23.31% year-over-year; the trailing twelve-month figure through Feb 2026 was $190467.0 (up 23.31% YoY), and the FY2025 annual result was $100343.0, down 39.5% from the prior year.
• Accounts Payables came in at $190467.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from $159116.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $257527.0 in Q1 2024 to a low of $100343.0 in Q2 2025.
• The 4-year median for Accounts Payables is $159116.0 (2025), against an average of $159665.0.
• Across the five-year window, Accounts Payables soared 49.02% in 2024 and tumbled 40.02% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Accounts Payables stood at $213521.0 in 2023, then declined by 22.2% to $166119.0 in 2024, then decreased by 4.22% to $159116.0 in 2025, then rose by 19.7% to $190467.0 in 2026.
• The last three Accounts Payables figures came in at $190467.0 (Q1 2026), $159116.0 (Q4 2025), and $101297.0 (Q3 2025), per Business Quant data.